Claudio Festuccia
Claudio Festuccia
Email verificata su - Home page
TitoloCitata daAnno
Bombesin stimulates growth of human prostatic cancer cells in vitro
M Bologna, C Festuccia, P Muzi, L Biordi, M Ciomei
Cancer 63, 1714-1720, 1989
Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors.
R De Maria, MG Cifone, R Trotta, MR Rippo, A Santoni, T Roberto
Journal of Experimental Medicine 180, 1999-2004, 1994
Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro
V Dolo, S D'ascenzo, S Violini, L Pompucci, C Festuccia, A Ginestra, ...
Clinical & experimental metastasis 17 (2), 131-140, 1999
Plasminogen activator system modulates invasivecapacity and proliferation in prostatic tumor cells
C Festuccia, V Dolo, F Guerra, S Violini, P Muzi, A Pavan, M Bologna
Clinical & experimental metastasis 16 (6), 513-528, 1998
Nucleo-cytoplasmic transport as a therapeutic target of cancer
GL Gravina, W Senapedis, D McCauley, E Baloglu, S Shacham, ...
Journal of hematology & oncology 7 (1), 85, 2014
Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
GL Gravina, C Festuccia, F Marampon, VM Popov, RG Pestell, BM Zani, ...
Molecular cancer 9 (1), 305, 2010
Osteoblast conditioned media contain TGF‐β1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components
C Festuccia, M Bologna, GL Gravina, F Guerra, A Angelucci, I Villanova, ...
International journal of cancer 81 (3), 395-403, 1999
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice
A Angelucci, GL Gravina, N Rucci, D Millimaggi, C Festuccia, P Muzi, ...
Endocrine-related cancer 13 (1), 197-210, 2006
Vitamin D Protects Human Endothelial Cells from H2O2 Oxidant Injury Through the Mek/Erk-Sirt1 Axis Activation
L Polidoro, G Properzi, F Marampon, GL Gravina, C Festuccia, ...
Journal of cardiovascular translational research 6 (2), 221-231, 2013
Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2
F Casilli, A Bianchini, I Gloaguen, L Biordi, E Alesse, C Festuccia, ...
Biochemical pharmacology 69 (3), 385-394, 2005
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro
I Recchia, N Rucci, C Festuccia, M Bologna, AR MacKay, S Migliaccio, ...
European Journal of Cancer 39 (13), 1927-1935, 2003
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines
A Angelucci, S D'ascenzo, C Festuccia, GL Gravina, M Bologna, V Dolo, ...
Clinical & experimental metastasis 18 (2), 163, 2000
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures
C Vicentini, C Festuccia, GL Gravina, A Angelucci, A Marronaro, ...
Journal of cancer research and clinical oncology 129 (3), 165-174, 2003
Osteoblast‐derived TGF‐β1 modulates matrix degrading protease expression and activity in prostate cancer cells
C Festuccia, A Angelucci, GL Gravina, I Villanova, A Teti, A Abini, ...
International journal of cancer 85 (3), 407-415, 2000
Finasteride dose-dependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitro
M Bologna, P Muzi, L Biordi, C Festuccia, C Vicentini
Urology 45 (2), 282-290, 1995
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity
C Festuccia, A Angelucci, GL Gravina, L Biordi, D Millimaggi, P Muzi, ...
Thrombosis and haemostasis 93 (05), 964-975, 2005
Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells
A Angelucci, C Festuccia, GL Gravina, P Muzi, L Bonghi, C Vicentini, ...
The Prostate 59 (2), 157-166, 2004
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and …
C Festuccia, D Giunciuglio, F Guerra, I Villanova, A Angelucci, P Manduca, ...
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 11 …, 1999
MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals
F Marampon, GL Gravina, A Di Rocco, P Bonfili, M Di Staso, C Fardella, ...
Molecular cancer therapeutics 10 (1), 159-168, 2011
Pyrazolo [3, 4-d] pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells
A Angelucci, S Schenone, GL Gravina, P Muzi, C Festuccia, C Vicentini, ...
European Journal of Cancer 42 (16), 2838-2845, 2006
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20